Allaman, 1., Belanger, M. & Magistretti, P.J. (2015) Methylglyoxal, the dark side of glycolysis. Front Neurosci, 9, 23-23.
Andreasen, N.C. (2000) Schizophrenia: the fundamental questions. Brain Research Reviews, 31,106- 112.
Arai, M., Yuzawa, H., Nohara, 1., Ohnishi,rΓ., Obata, N., Iwayama, Y., Haga, S., Toyota, T., Ujike, H., Arai, M., Ichikawa, T., Nishida, A., Tanaka, Y., Furukawa, A., Aikawa, Y., et al.(2010) Enhanced carbonyl stress in a subpopulation of schizophrenia. Archives of general psychiatry, 67, 589-597.
Balan, S., Iwayama, Y., Toyota, T., Toyoshima, M., Maekawa, M. & Yoshikawa, T. (2014) 22qll.2 deletion carriers and schizophrenia-associated novel variants. British Journal of Psychiatry, 204, 398-399.
Balan, S., Toyoshima, M. & Yoshikawa, T. (2019) Contribution of induced pluripotent stem cell technologies to the understanding of cellular phenotypes in schizophrenia. Neurobiol Dis, 131, 104162.
Birnbaum, R. & Weinberger, D.R. (2017) Genetic insights into the neurodevelopmental origins of schizophrenia. Nature reviews. Neuroscience,18, 727-740.
Brennand, K., Savas, J.N., Kim, Y., Tran, N., Simone, A., Hashimoto-Torii, K., Beaumont, K.G., Kim, H.J., Topol, A., Ladran, 1., Abdelrahim, M., Matikainen-Ankney, B., Chao, S.H., Mrksich, M., Rakic, P., et al.(2015) Phenotypic differences in hiPSC NPCs derived from patients with schizophrenia. MolPsychiatry, 20, 361-368.
Byun, K., Yoo, Y., Son, M., Lee, J., Jeong, G.B., Park, Y.M., Salekdeh, G.H. & Lee, B. (2017) Advanced glycation end-products produced systemically and by macrophages: A common contributor to inflammation and degenerative diseases. Pharmacol Ther, 177, 44-55.
Cai, W., Duan, X.-M., Liu, Y., Yu, J., Tang, Y.-L., Liu, Z.-L., Jiang, S., Zhang, C.-P., Liu, J.-Y. & Xu, J. (2017) Uric Acid Induces Endothelial Dysfunction by Activating the HMGB1/RAGE Signaling Pathway. BioMed Research International, 2017, 1-11.
Chen, Y.-J., Huang, X.-B., Li, Z.-X., Yin, L.-L., Chen, W.-Q. & Li, L. (2010) Tenuigenin protects cultured hippocampal neurons against methylglyoxal-induced neurotoxicity. European Journal of Pharmacology, 645, 1-8.
Comer, A.L., Carrier, M., Tremblay, M.-E. & Cruz-Martin, A. (2020) The Inflamed Brain in Schizophrenia: The Convergence of Genetic and Environmental Risk Factors That Lead to Uncontrolled Neuroinflammation. Frontiers in しellular Neuroscience,14.
Cradick, T.J., Qiu, P., Lee, C.M., Fine, E.J. & Bao, G. (2014) COSMID: A Web-based Tool for Identifying and Validating CRISPR/Cas Off-target Sites. Mol Ther Nucleic Acids, 3, e214.
Di Loreto, S., Caracciolo, V., Colafarina, S., Sebastiani, P., Gasbarri, A. & Amicarelli, F. (2004) Methylglyoxal induces oxidative stress-dependent cell injury and up-regulation of interleukin-1 β and nerve growth factor in cultured hippocampal neuronal cells. Brain research, 1006, 157- 167.
Doki, T., Yamashita, S., Wei, F.-Y., Hara, K., Yamamoto, T., Zhang, Z., Zhang, X., Tawara, N., Hino, H., Uyama, E., Kurashige, T., Maruyama, H., Tomizawa, K. & Ando, Y. (2019) Mitochondrial localization of PABPN1 in oculopharyngeal muscular dystrophy. Laboratory In vestigation, 99, 1728-1740.
Drygalski, K., Fereniec, E., Zalewska, A., Kr^towski, A., Zendzian-Piotrowska, M. & Maciejczyk, M. (2021)Phloroglucinol prevents albumin glycation as well as diminishes ROS production, glycooxidative damage, nitrosative stress and inflammation in hepatocytes treated with high glucose. Biomedicine & Pharmacotherapy, 142, 111958.
Fujimori, K., Ishikawa, M., Otomo, A., Atsuta, N., Nakamura, R., Akiyama, T., Hadano, S., Aoki, M., Saya, H., Sobue, G. & Okano, H. (2018) Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent. Nature Medicine, 24,1579-1589.
Fujimoto, M., Uchida, S., Watanuki,rΓ., Wakabayashi, Y., Otsuki, K., Matsubara, T., Suetsugi, M., Funato, H. & Watanabe, Y. (2008) Reduced expression of glyoxalase-1 mRNA in mood disorder patients. Neuroscience letters, 438, 196-199.
Futamura, Y., Muroi, Μ., Aono, H., Kawatani, M., Hayashida, M., Sekine, T., Nogawa, T. & Osada, H. (2019) Bioenergetic and proteomic profiling to screen small molecule inhibitors that target cancer metabolisms. Biochim Biophys Acta Proteins Proteom, 1867, 28-37.
Gabriele, S., Lombardi, F., Sacco, R., Napolioni,1V., Altieri, L., Tirindelli, M.C., Gregorj, C., Bravaccio, C., Rousseau, F. & Persico, A.M. (2014) The GLO1 C332 (Alai11)allele confers autism vulnerability: Family-based genetic association and functional correlates. Journal of Psychiatric Research, 59,108-116.
Gaffney, D.O., Jennings, E.Q., Anderson, C.C., Marentette, J.O., Shi,Γ., Schou Oxvig, A.-M., Streeter, M.D., Johannsen, M., Spiegel, D.A., Chapman, E., Roede, J.R. & Galligan, J.J. (2020) Non- enzymatic Lysine Lactoylation of Glycolytic Enzymes. Cell Chemical Biology, 27, 206- 213.e206.
Giordano, G., Hong, S., Faustman, E.M. & Costa, L.G. (2011)Measurements of Cell Death in Neuronal and Glial Cells. In In Vitro Neurotoxicology: Methods and Protocols, edited by Costa, L.G., Giordano, G. & Guizzetti, M. Humana Press, Totowa, NJ, pp.171-178.
Gogtay, N., Vyas, N.S., Testa, R., Wood, S.J. & Pantelis, O. (2011)Age of onset of schizophrenia: perspectives from structural neuroimaging studies. Schizophr Bull, 37, 504-513.
Habarou, F., Hamel,Y., Haack, T.B., Feichtinger, R.G., Lebigot, E., Marquardt, 1., Busiah, K., Laroche, C., Madrange, M., Grisel,C., Pontoizeau, C., Eisermann, M., Boutron, A., Chretien, D., Chadefaux-Vekemans, B., et al.(2017) Biallelic Mutations in LIPT2 Cause a Mitochondrial Lipoylation Defect Associated with Severe Neonatal Encephalopathy. The American Journal of Human Genetics,101,283-290.
Hirai, S., Miwa, H., Tanaka, T., Toriumi, K., Kunii, Y., Shimbo, H., Sakamoto, T., Hino, M., Izumi, R., Nagaoka, A., Yabe, H., Nakamachi, T., Shioda, S., Dan, T., Miyata, T., et al.(2021)High- sucrose diets contribute to brain angiopathy with impaired glucose uptake and psychosis- related higher brain dysfunctions in mice. Sci Adv, 7, eabl6077.
Ide, M., Ohnishi, T., Toyoshima, M., Balan, S., Maekawa, M., Shimamoto-Mitsuyama, C., Iwayama, Y., Ohba, H., Watanabe, A., Ishii,rΓ., Shibuya, N., Kimura, Y., Hisano, Y., Murata, Y., Hara, T., et al.(2019) Excess hydrogen sulfide and polysulfides production underlies a schizophrenia pathophysiology. EMBO Mol Med,11,el0695.
Itokawa, M., Miyashita, M., Arai, M., Dan, T., Takahashi, K., Tokunaga, T., Ishimoto, K., Toriumi, K., Ichikawa, T., Horiuchi, Y., Kobori, A., Usami, S., Yoshikawa, T., Amano, N., Washizuka, S., et al.(2018) Pyridoxamine: A novel treatment for schizophrenia with enhanced carbonyl stress. Psychiatry Clin Neurosci, 72, 35-44.
Jin, Z. & El-Deiry, W.S. (2005) Overview of cell death signaling pathways. Cancer Biology & Therapy, 4,147-171.
Junaid, M.A., Kowal,D., Barua, M., Pullarkat, P.S., Sklower Brooks, S. & Pullarkat, R.K. (2004) Proteomic studies identified a single nucleotide polymorphism in glyoxalase I as autism susceptibility factor. American Journal of Medical Genetics Part A,丄 31 A, 11-17.
Kawatani, M., Okumura, H., Honda, K., Kanoh, N., Muroi, M., Dohmae, N., Takami, M., Kitagawa, M., Futamura, Y., Imoto, M. & Osada, H. (2008) The identification of an osteoclastogenesis inhibitor through the inhibition of glyoxalase I. Proceedings of the National Academy of Sciences, 105, 11691.
Kikuchi, S., Shinpo, K., Moriwaka, F., Makita, Z., Miyata, T. & Tashiro, K.(1999) Neurotoxicity of methylglyoxal and 3-deoxyglucosone on cultured cortical neurons: Synergism between glycation and oxidative stress, possibly involved in neurodegenerative diseases. Journal of neuroscience research, 57, 280-289.
Kinsky, O.R., Hargraves, T.L., Anumol,T., Jacobsen, N.E., Dai, J., Snyder, S.A., Monks, T.J. & Lau, S.S. (2016) Metformin Scavenges Methylglyoxal To Form a Novel Imidazolinone Metabolite in Humans. Chemical Research in Toxicology, 29, 227-234.
Koike, S., Toriumi, K., Kasahara, S., Kibune, Y., Ishida, Y.-i., Dan, T., Miyata, T., Arai, M. & Ogasawara, Y. (2021)Accumulation of Carbonyl Proteins in the Brain of Mouse Model for Methylglyoxal Detoxification Deficits. Antioxidants,10, 574.
Kovac, J., Podkrajsek, K.T., Luksic, M.M. & Battelino, T. (2015) Weak association of glyoxalase 1 (GLO1) variants with autism spectrum disorder. European Child & Adolescent Psychiatry, 24, 75-82.
Kuhla, B., Boeck, K., Schmidt, A., Ogunlade, V., Arendt, T., Munch, G. & Luth, H.J. (2007) Age- and stage-dependent glyoxalase I expression and its activity in normal and Alzheimer's disease brains. Neurobiol Aging, 28, 29-41.
Langmead, B., Trapnell,C., Pop, M. & Salzberg, S.L. (2009) Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biology,10, R25.
Lorenz, C., Lesimple, P., Bukowiecki, R., Zink, A., Inak, G., Mlody, B., Singh, M., Semtner, M., Mah, N., Aure, K., Leong, M., Zabiegalov, O., Lyras, E.M., Pfiffer, V., Fauler, B., et al.(2017) Human iPSC-Derived Neural Progenitors Are an Effective Drug Discovery Model for Neurological mtDNA Disorders. Cell Stem Cell,20, 659-674 e659.
Lyons, T.J. & Jenkins, A.J.(1997) Glycation, oxidation, and lipoxidation in the development of the complications of diabetes: a carbonyl stress hypothesis. Diabetes Rev (Alex), 5, 365-391.
Malhotra, J.D. & Kaufman, R.J. (2007) Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword? AntioxidRedox Signal,9, 2277-2293.
Miyashita, M., Arai, M., Kobori, A., Ichikawa, T., Toriumi, K., Niizato, K., Oshima, K., Okazaki, Y., Yoshikawa, T., Amano, N., Miyata, T. & Itokawa, M. (2014) Clinical features of schizophrenia with enhanced carbonyl stress. Schlzophr Bull,40,1040-1046.
Miyata, T., Saito, A., Kurokawa, K. & de Strihou, C.v.Y. (2001)Advanced glycation and lipoxidation end products: reactive carbonyl compounds - related uraemic toxicity. Nephrology Dialysis Transplantation,16, 8-11.
Morcos, M., Du, X., Pfisterer, F., Hutter, H., Sayed, A.A., Thornalley, P., Ahmed, N., Baynes, J., Thorpe, S., Kukudov, G., Schlotterer, A., Bozorgmehr, F., El Baki, R.A., Stern, D., Moehrlen, F., et al.(2008) Glyoxalase-1 prevents mitochondrial protein modification and enhances lifespan in Caenorhabditis elegans. Aging Cell,7, 260-269.
Mostafa, A.A., Randell, E.W., Vasdev, S.C., Gill, V.D., Han, Y., Gadag, V., Raouf, A.A. & El Said, H. (2007) Plasma protein advanced glycation end products, carboxymethyl cysteine, and carboxyethyl cysteine, are elevated and related to nephropathy in patients with diabetes. Molecular and Cellular Biochemistry, 302, 35-42.
Murphy, Michael P. (2013) Mitochondrial Dysfunction Indirectly Elevates ROS Production by the Endoplasmic Reticulum. Cell Metabolism,18,145-146.
Nagai, R., Murray, D.B., Metz, T.O. & Baynes, J.W. (2012) Chelation: a fundamental mechanism of action of AGE inhibitors, AGE breakers, and other inhibitors of diabetes complications. Diabetes, 61,549-559.
Ohnishi,rΓ., Balan, S., Toyoshima, M., Maekawa, M., Ohba, H., Watanabe, A., Iwayama, Y., Fujita, Y., Tan, Y., Hisano, Y., Shimamoto-Mitsuyama, C., Nozaki, Y., Esaki, K., Nagaoka, A., Matsumoto, J., et al.(2019) Investigation of betaine as a novel psychotherapeutic for schizophrenia. EBioMedicine, 45, 432-446.
Ohnuma, T., Nishimon, S., Takeda, M., Sannohe, T., Katsuta, N. & Aral,H. (2018) Carbonyl Stress and Microinflammation-Related Molecules as Potential Biomarkers in Schizophrenia. Front Psychiatry, 9, 82.
Owen, M.J., O,Donovan, M.C., Thapar, A. & Craddock, N. (2011)Neurodevelopmental hypothesis of schizophrenia. Br J Psychiatry, 198, 173-175.
Owen, M.J., Sawa, A. & Mortensen, P.B. (2016) Schizophrenia. Lancet (London, England), 388, 86- 97.
Pampati, P.K., Suravajjala, S. & Dain, J.A. (2011)Monitoring nonenzymatic glycation of human immunoglobulin G by methylglyoxal and glyoxal:A spectroscopic study. AnalBiochem, 408, 59-63.
Polykretis, P., Luchinat, E., Boscaro, F. & Banci, L. (2020) Methylglyoxal interaction with superoxide dismutase 1.Redox Biology, 30,101421.
Rabbani, N. & Thornalley, P.J. (2014) Measurement of methylglyoxal by stable isotopic dilution analysis LC-MS/MS with corroborative prediction in physiological samples. Nature Protocols, 9,1969-1979.
Rajasekaran, A., Venkatasubramanian, G., Berk, M. & Debnath, M. (2015) Mitochondrial dysfunction in schizophrenia: pathways, mechanisms and implications. NeurosciBiobehavRev, 48,10-21.
Rangaraju, V., Lewis, T.L., Hirabayashi, Y., Bergami, M., Motori, E., Cartoni, R., Kwon, S.-K. & Courchet, J. (2019) Pieiotropic Mitochondria: The Influence of Mitochondria on Neuronal Development and Disease. The Journal of Neuroscience, 39, 8200-8208.
Redza-Dutordoir, M. & Averill-Bates, D.A. (20丄ノ Activation of apoptosis signalling pathways by reactive oxygen species. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1863, 2977-2992.
Rodriguez, L.R., Calap-Quintana, P., Lapena-Luzon, T., Pallardo, F.V., Schneuwly, S., Navarro, J.A. & Gonzalez-Cabo, P. (2020) Oxidative stress modulates rearrangement of endoplasmic reticulum-mitochondria contacts and calcium dysregulation in a Friedreich's ataxia model. Redox Biology, 37,101762.
Roorda, M.M. (2017) Therapeutic interventions against accumulation of advanced glycation end products (AGEs). Glycative Stress Research, 4,132-143.
Rosea, M.G., Mustata, T.G., Kinter, M.T., Ozdemir, A.M., Kern, T.S., Szweda, L.I., Brownlee, M., Monnier, V.M. & Weiss, M.F. (2005) Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation. Am J Physiol Renal Physiol, 289, F420- 430.
Sharma, C., Kaur, A., Thind, S.S., Singh, B. & Raina, S. (2015) Advanced glycation End-products (AGEs): an emerging concern for processed food industries. J Food Sci Technol,52, 7561- 7576.
Shinohara, M., Thornalley, P.J., Giardino, 1., Beisswenger, P., Thorpe, S.R., Onorato, J. & Brownlee, M.(1998) Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. The Journal of clinical investigation,101,1142-1147.
Sivandzade, F., Bhalerao, A. & Cucullo, L. (2019) Analysis of the Mitochondrial Membrane Potential Using the Cationic JC-1 Dye as a Sensitive Fluorescent Probe. Bio Protoc, 9.
Son, S., Arai, M., Miyata, J., Toriumi, K., Mizuta, H., Hayashi, T., Aso, T., Itokawa, M. & Murai, T. (2020) Enhanced carbonyl stress and disrupted white matter integrity in schizophrenia. Schizophrenia research.
Sousa Silva, M., Gomes, Ricardo A., Ferreira, Antonio E.N., Ponces Freire, A. & Cordeiro, C. (2013) The glyoxalase pathway: the first hundred years··· and beyond. BiochemicalJournal, 453, 1-15.
Szwergold, B. (2018) A Hypothesis: Moderate Consumption of Alcohol Contributes to Lower Prevalence of Type 2 Diabetes Due to the Scavenging of Alpha-Dicarbonyls by Dietary Polyphenols. Rejuvenation Res, 21,389-404.
Tandon, R., Gaebel,W., Barch, D.M., Bustillo, J., Gur, R.E., Heckers, S., Malaspina, D., Owen, M.J., Schultz, S., Tsuang, M., Van Os, J. & Carpenter, W. (2013) Definition and description of schizophrenia in the DSM-5. Schizophrenia research, 150, 3-10.
Thornalley, P.J. (2005) Dicarbonyl Intermediates in the Maillard Reaction. Annals of the New York Academy of Sciences, 1043, 111-117.
Thornalley, P.J. (2003) Glyoxalase I--structure, function and a critical role in the enzymatic defence against glycation. Biochem Soc Trans, 31,1343-1348.
Toriumi, K., Berto, S., Koike, S., Usui, N., Dan, T., Suzuki, K., Miyashita, M., Horiuchi,1 i., Yoshikawa, A., Asakura, M., Nagahama, K., Lin, H.-C., Sugaya, Y., Watanabe, T., Kano, M., et al.(2021) Combined glyoxalase 1 dysfunction and vitamin B6 deficiency in a schizophrenia model system causes mitochondrial dysfunction in the prefrontal cortex. Redox Biology, 45,102057.
Toyoshima, M., Akamatsu, W., Okada, Y., Ohnishi, T., Balan, S., Hisano, Y., Iwayama, Y., Toyota, T., Matsumoto, T., Itasaka, N., Sugiyama, S., Tanaka, M., Yano, M., Dean, B., Okano, H., et al. (2016) Analysis of induced pluripotent stem cells carrying 22qll.2 deletion. TranslPsychiatry, 6, e934.
Toyoshima, M., Jiang, X., Ogawa, T., Ohnishi,rΓ., Yoshihara, S., Balan, S., Yoshikawa, T. & Hirokawa, N. (2019) Enhanced carbonyl stress induces irreversible multimerization of CRMP2 in schizophrenia pathogenesis. Life Sei Alliance, 2.
Toyosima, M., Maekawa, M., Toyota, T., Iwayama, Y., Aral,M., Ichikawa, T., Miyashita, M., Arinami, T., Itokawa, M. & Yoshikawa, T. (2011)Schizophrenia with the 22qll.2 deletion and additional genetic defects: case history. Br J Psychiatry, 199, 245-246.
Trapnell,C., Roberts, A., Goff, L., Pertea, G., Kim, D., Kelley, D.R., Pimentel,H., Salzberg, S.L., Rinn, J.L. & Pachter, L. (2012) Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nature Protocols, 7, 562-578.
Traverso, N., Menini, S., Cottalasso, D., Odetti, P., Marinari, U.M. & Pronzato, M.A.(1997) Mutual interaction between glycation and oxidation during non-enzymatic protein modification. Biochimica et Biophysica Acta (BBA) - General Subjects, 1336, 409-418.
Voziyan, P.A., Metz, T.O., Baynes, J.W. & Hudson, B.G. (2002) A post-Amadori inhibitor pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation. J Biol Chem, 277, 3397-3403.
Wang, C. & Youle, R.J. (2009) The role of mitochondria in apoptosis*. Annu Rev Genet, 43, 95-118.
Weinberger, D.R. (2017) Future of Days Past: Neurodevelopment and Schizophrenia. Schizophrenia Bulletin, 43,1164-1168.
Xue, J., Ray, R., Singer, D., Bohme, D., Burz, D.S., Rai, V., Hoffmann, R. & Shekhtman, A. (2014) The receptor for advanced glycation end products (RAGE) specifically recognizes methylglyoxal- derived AGEs. Biochemistry, 53, 3327-3335.
Xue, M., Rabbani, N. & rhornalley, P.J. (2011)Glyoxalase in ageing. Seminars in Cell & Developmental Biology, 22, 293-301.
論文の公開元へ
